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Edited by Lev KisselevAbstract Haem controls its own synthesis in non-erythroid
cells primarily by regulation of ALAS1 mRNA stability. Alter-
native splicing of human ALAS1 generates two mRNAs with
diﬀerent 5 0-UTRs: a major one, where exon 1B is omitted,
and a minor form containing exon 1B. We show that, unlike
the major ALAS1 mRNA, the minor form was resistant to
haem-mediated decay. Furthermore, we demonstrate that the
ALAS1 5 0-UTR alone did not confer haem-mediated decay
upon a heterologous mRNA and the inclusion of exon 1B
inhibited translation. These data suggest that translation of
ALAS1 mRNA itself might be required for destabilisation in
response to haem.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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5 0-UTR1. Introduction
Haem is essential for life playing a vital role in many ubiq-
uitous and tissue-speciﬁc cellular processes through its bind-
ing and function as a prosthetic group in a diverse array of
cellular hemoproteins. It regulates its own synthesis in non-
erythroid cells through a regulatory intracellular haem pool
(10–100 nM), which is maintained by distinct haem-depen-
dent control of aminolaevulinate synthase 1 (ALAS1), and
haem oxygenase-1 [1]. ALAS1 is the ﬁrst and rate controlling
enzyme of haem biosynthesis and catalyses the condensation
of glycine and succinyl-CoA to form ALA in the mitochon-
drial matrix. The ALAS1 gene is expressed in both erythroid
and non-erythroid cells, although its expression varies be-
tween tissues [2]. Highest levels are found in the liver where
ALAS1 transcription can be induced directly by compounds
such as phenobarbital to co-ordinate an increased demandAbbreviations: ALAS1, aminolaevulinate synthase 1; DMEM, Dul-
beccos modiﬁed Eagle medium; GAPDH, glyceraldehyde-3-phosphate
dehydrogenase; EtBr, ethidium bromide; uORF, upstream open rea-
ding frame
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Whilst haem has been reported to regulate transcription of
ALAS1 in some cells [2], but not others [5], it primarily con-
trols its own synthesis post-transcriptionally: through inhibi-
tion of the import of pre-ALAS1 to the mitochondrial
matrix [6,7] and regulation of ALAS1 mRNA stability
[5,8–10].
Haem-mediated destabilisation of hepatic ALAS1 mRNA
has been demonstrated in cells across a variety of species
including chick hepatocytes [8], rat CWSV17 hepatoma cells
[9] and human HepG2 hepatoma cells [10]. Inhibitors of pro-
tein synthesis have been shown to stabilise ALAS1 mRNA
and block haem-mediated decay leading to the suggestion that
the haem eﬀect requires a labile protein [8,11]. Despite these
observations, however, the precise molecular mechanism by
which haem regulates ALAS1 mRNA stability remains
unknown.
The organisation of the human ALAS1 gene is similar to
the orthologous rat, mouse and chicken genes, except that
it contains two non-coding exons (1A and 1B) in its 5 0-
UTR, unlike the rat gene, which contains one [12], and the
chicken, which has none [13]. We have shown previously that
exon 1B of the human gene is alternatively spliced resulting
in two mRNA species: a major one, in which it is omitted
and a minor one containing both exons 1A and 1B [14]. This
longer mRNA is present in all tissues and cell lines examined
and represents approximately 10% of the steady state con-
centration of ALAS1 mRNA. Here we demonstrate for the
ﬁrst time that, unlike the major ALAS1 mRNA, the minor
form is resistant to haem-mediated decay and its altered
5 0-UTR represses translation, which suggests strongly that
haem-mediated destabilisation of ALAS1 mRNA requires
its translation.2. Materials and methods
2.1. Materials
Oligonucleotides were purchased from Eurogentec (Southampton,
England) or Invitrogen (Paisley, Scotland). All cell culture reagents
were obtained from Invitrogen. Actinomycin D and hemin purchased
from Sigma–Aldrich (Gillingham, England). Ultraspec RNA Reagent
was bought from AMS Biotechnology (Abingdon, England). DNA/
RNA modifying enzymes and restriction endonucleases came either
from Invitrogen or Promega (Southampton, England) unless otherwise
stated.blished by Elsevier B.V. All rights reserved.
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The HepG2 human hepatoma cell line (ECACC No. 85011430)
was obtained from the European Collection of Cell Cultures (Porton
Down, England). Cells were cultured in Dulbeccos modiﬁed Eagle
medium (DMEM) supplemented with 10% Foetal Calf Serum and
2 mM L-glutamine at 37 C in a humidiﬁed atmosphere with 5%
CO2.
In experiments where cells were treated with haem, a 20 mM solu-
tion of hemin in 0.2 M KOH/100% ethanol (1:1 v/v) was diluted ten-
fold with culture medium to give a 2 mM stock solution [15,16], which
was subsequently diluted in culture medium to achieve the appropriate
working concentration.
2.3. RT-PCR and PCR
Total RNA was isolated using Ultraspec according to the manufac-
turers instructions and its concentration and purity determined spec-
trophotometrically at 260 and 280 nm. For RT-PCR, ﬁrst strand
cDNA synthesis was performed at 42 C for 1 h using 200U
MMLV-reverse transcriptase with 2 lg total RNA primed by oli-
go(dT)15. Unless otherwise stated, DNA fragments were ampliﬁed in
50 ll reaction volumes using 25 pmols of each primer and 5U Hot
Start Taq polymerase (Qiagen, Sussex, England) with the cycling reac-
tions performed on a PCR Sprint Thermal Cycler (Thermo Electron,
Basingstoke, England).
The primers used and their sequences are shown in the table below:Primer Target sequence Primer sequence 5 0–3 0 Orientation
P1 ALAS1 mRNA minor 5 0-UTR CAGCGCAGTTATGCCCA Sense
P2 ALAS1 mRNA major 50-UTR CAGCGCAGTCTTTCCAC Sense
P3 ALAS1 mRNA exon 3 CTGTGCTGCCAGGAAGAAGCA Antisense
P4 GAPDH mRNA CCATCACCATCTTCCAGGAG Sense
P5 GAPDH mRNA GGATGATGTTCTGGAGAGCC Antisense
P6 ALAS1 mRNA exon 1A AAGCTT CTGCTCCCGGACAAGGGCAAC Sense
P7 ALAS1 mRNA exon 2 CCATGG TCAGGAAGTATGCTGGCTCC AntisenseItalicised bases indicate restriction endonuclease recognition sites
and non-italicised lower case letters refer to sequences not complemen-
tary to target nucleic acids.
To investigate the eﬀect of haem upon the stability of the ALAS1
mRNAs, HepG2 cells, in the absence or presence of haem (20 lM),
were treated with actinomycin D (5 lg/ml) and harvested at 1, 2, 4
and 8 h when total RNA was isolated. Each of the ALAS1 mRNAs
was ampliﬁed speciﬁcally using diﬀerent sense primers corresponding
to the sequences across the exon 1A/1B boundary (primer P1) or the
exon 1A/2 boundary (P2), to minimise competition for the two cDNA
templates, and an antisense primer (P3) derived from sequence in exon
3. The conditions were optimised for logarithmic ampliﬁcation using
untreated control cells. To ensure results were normalised for equiva-
lent concentrations of RNA, a 404 bp GAPDH cDNA fragment was
also ampliﬁed using sense (P4) and antisense (P5) primers. Following
agarose gel electrophoresis, EtBr-stained ampliﬁed DNA was visual-
ised using a Syngene Gene Genius documentation system (Syngene,
Cambridge, England) and quantiﬁed by densitometry. Decay curves
were plotted at equivalent GAPDH concentrations and half-life mea-
surements calculated from the best-ﬁt slope through the data.
2.4. Plasmid construction
To investigate the role of ALAS1 5 0-UTRs in haem-mediated stabil-
ity and to determine their eﬀects upon translation, cDNA fragments
for both the major and minor mRNAs were ampliﬁed from the major
hepatic transcription start site in exon 1 to the initiating ATG in exon 2
with 1U Bio-X-ACT Polymerase (Bioline, London, England) using the
P6 and P7 primers, which contained HindIII and NcoI restriction sites,
respectively. cDNAs were subsequently puriﬁed using a QIAquick
PCR Clean-up Kit (Qiagen) and cloned into the pGEM-T vector (Pro-
mega). Recombinant plasmid DNA was puriﬁed using a QIAprep spin
kit (Qiagen) and the identities of the clones for the long and short 5 0-
UTRs conﬁrmed by automated ﬂuorescent sequencing using Big Dye
chemistry and analysis on an ABI Prism 3100 genetic analyser (Ap-
plied Biosystems, Warrington, England). Inserts from positive cloneswere removed by digestion with HindIII and NcoI and subcloned into
HindIII/NcoI digested pGL3-Promoter vector (Promega). The NcoI
site contains the initiating ATG of ﬁreﬂy luciferase thereby excluding
any vector-derived 5 0-UTR sequence.
To test for potential transcriptional activity, these same ALAS1
fragments were ligated into HindIII/NcoI digested pGL3-basic vector
(Promega), which lacks eukaryotic promoter and enhancer sequences.
2.5. Transfections and dual luciferase reporter assay
Transfections were carried out using Lipofectamine 2000 (Invitro-
gen). Brieﬂy, HepG2 cells were trypsinised and seeded in 12-well plates
at a density such that they were 80% conﬂuent on the following day
when they were transfected. pGL3-derived experimental constructs
were used at 1 lg per well and co-transfected with the pRL-CMV plas-
mid (0.1 lg) for normalisation purposes. Transfected cells were lysed
using Passive Lysis Buﬀer and luciferase activity monitored in lysed cell
extracts by a Dual Luciferase Reporter Assay (Promega) using a Lumat
LB 9507 Luminometer (EG&G Berthold, Bad Wildbad, Germany).3. Results
Previous work in this laboratory has shown that alternative
splicing of the human ALAS1 gene generates two mRNA spe-cies: a major one, in which exon 1B is omitted, and a ubiqui-
tously expressed minor one containing both exons 1A and 1B,
which accounts for about 10% of the steady-state concentration
of ALAS1mRNA [14]. Preliminary data indicated that themin-
orALAS1mRNAwasmore resistant to destabilisation by haem
than the major mRNA and we set out to investigate this further.
HepG2 cells were subjected to treatment with actinomycin D to
induce transcriptional arrest. Following the addition of exoge-
nous haem (20 lM), levels of themajor ALAS1mRNAhad fall-
en to 15% of their original levels by 8 h, whereas in untreated
cells, they had dropped to 40% (Fig. 1). The major ALAS1
mRNA half-life, calculated from the best-ﬁt curve, was reduced
more than two-fold from 6.2 h in untreated cells to 2.9 h in cells
exposed to haem. In contrast, levels of theminorALAS1mRNA
remained essentially unchanged throughout the duration of the
experiment in both haem-treated and untreated control cells
indicating that unlike the major form in HepG2 cells, it is resis-
tant to haem-mediated decay.
One straightforward explanation for this contrasting stability
is that haem regulation is mediated through a cis-acting element
located within the 5 0-UTR, which is disrupted in the minor
ALAS1 mRNA owing to inclusion of non-coding exon 1B. An
alternative interpretation is that haem-insensitivity of the minor
ALAS1 mRNA might be a result of reduced translation, since
inhibition of protein synthesis has been shown to prevent
haem-mediated ALAS1mRNAdecay [8,11] whilst alternatively
spliced, non-coding exons are known to inhibit downstream
translation [17]. Therefore, in order to determine whether the
ALAS1 5 0-UTR was able to confer haem-mediated decay upon
Fig. 1. Eﬀect of haem upon stability of the major and minor ALAS1
mRNAs in HepG2 cells. Cells were treated with actinomycin D (5 lg/
ml) and left, or exposed to 20 lM haem for up to 8 h. Major and minor
ALAS1 mRNAs, shown as the upper and lower bands respectively in
each panel, were ampliﬁed speciﬁcally by RT-PCR. The bottom panel
shows the results of cells exposed to haem and the upper panel those
without haem. Equivalent total cDNA concentrations between sam-
ples were conﬁrmed by co-ampliﬁcation of GAPDH cDNA (not
shown). Experiments were carried out in triplicate on three separate
occasions with similar results obtained each time. Decay curves were
plotted at equivalent GAPDH concentrations and t1/2 measurements
calculated from the best-ﬁt slope through the data. These showed that
in the presence of haem, the t1/2 for the major ALAS1 mRNA was
reduced from 6.2 to 2.9 h. No calculations were made for the minor
ALAS1 mRNA since its stability was relatively unaﬀected by haem.
Fig. 2. Eﬀect of ALAS1 mRNA 5 0-UTRs upon ﬁreﬂy luciferase
activity and response to haem. The parental pGL3P, pGLALASmaj
and pGLALASmin 5 0-UTR ﬁreﬂy luciferase constructs were sepa-
rately co-transfected along with pRL-CMV into human HepG2 cells.
Bioluminescent activity was measured using the Dual Luciferase
Reporter Assay after 48 h after transfection. Haem was added for 24 h
before harvesting where indicated. The bars show normalised ﬁreﬂy
luciferase activity relative to the pGL3P (minus haem) data which was
arbitrarily considered to be 1. Results shown represent mean (±S.D.)
of at least three experiments performed in triplicate. Statistical analysis
was performed using a paired t test. No signiﬁcant diﬀerence was
observed between normalised ﬁreﬂy luciferase activity in untreated
cells (with vehicle only) and those treated with haem for any of the
constructs.
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minor 5 0-UTR can inhibit its translation, we cloned the major
and minor 5 0-UTRs immediately upstream of ﬁreﬂy luciferase
cDNA in the pGL3-promoter (pGL3P) vector to produce two
reporter constructs, designated pGLALASmaj and pGLALAS-
min respectively, with which we transfected HepG2 cells.
As indicated clearly in Fig. 2, haem exposure did not signif-
icantly aﬀect normalised ﬁreﬂy luciferase activity produced by
either of these constructs or the parental pGL3P vector. These
results imply that the ALAS1 5 0-UTR does not contain cis-act-
ing elements that can function independently to confer haem-
mediated instability.
These data also showed conclusively that there were signiﬁ-
cant diﬀerences in ﬁreﬂy luciferase activity between the con-
structs. Normalised ﬁreﬂy luciferase activity in cells
transfected with the pGLALASmaj construct was 4.7-fold
higher than that from cells transfected with the parental
pGL3P vector. In contrast, normalised ﬁreﬂy luciferase activ-
ity in cells transfected with the pGLALASmin plasmid was
nearly two-fold less than in pGL3P-transfected cells.
To ensure that these diﬀerences did not result from variations
in ﬁreﬂy luciferase mRNA expression, we performed RT-PCR
analysis (Fig. 3(a)), which showed that no diﬀerences in ﬁreﬂy
luciferase mRNA levels between cells transfected with the pGL-
ALASmaj or pGLALASmin constructs. In both cases, these
were approximately ﬁve-fold higher than those from control
pGL3P-transfected cells. As Fig. 2 showed, in pGLALASmaj-
transfected cells, this enhanced ﬁreﬂy luciferase mRNA expres-
sion resulted in a proportionate increase in ﬁreﬂy luciferase
activity, but, on the contrary, the elevated ﬁreﬂy luciferase
mRNA expression in pGLALASmin-transfected cells did not
produce a commensurate augmentation in ﬁreﬂy luciferase
activity. Thus, despite producing equivalent levels of mRNA
to those in pGLALASmaj-transfected cells, ﬁreﬂy luciferase
activity was approximately 90% lower in pGLALASmin-trans-
fected cells. Clearly therefore, the inclusion of exon 1B in theminor 5 0-UTR must have inhibited translation of the down-
stream ﬁreﬂy luciferase open reading frame. This indicates
strongly that the minor ALAS1mRNA is comparatively poorly
translated under normal conditions in HepG2 cells.
The enhanced ﬁreﬂy luciferase mRNA expression observed
with both the major and minor ALAS1 5 0-UTR constructs is
due to intrinsic transcriptional activity. We demonstrated this
by cloning the ALAS1 major and minor 5 0-UTRs into the pro-
moterless pGL3-basic vector. As expected, RT-PCR analysis
showed that there was no substantial ﬁreﬂy luciferase mRNA
production and consequently no luciferase activity in cells
transfected with the parental pGL3-basic vector (data not
shown). As Fig. 3(b) shows, both the ALAS1 5 0-UTR con-
structs, designated pBALASmaj and pBALASmin, produced
ﬁreﬂy luciferase mRNA, but ﬁreﬂy luciferase activity from
the pBALASmin construct was approximately 90% lower than
that from the pBALASmaj construct, exactly mirroring the
data observed with the pGL3-promoter derived constructs
and again conﬁrming that translation of the minor transcript
is inhibited. Additionally, these data indicate that transcription
in the promoterless ALAS1 5 0-UTR constructs must emanate
from sequences upstream of exon 1B, i.e., within exon1A,
which is common to both.4. Discussion
The ability of haem to control its own synthesis in all cells is
vital [1]. High intracellular concentrations of haem are cyto-
toxic, damaging cells through oxidative processes involving
Fig. 3. ALAS1 major and minor 5 0-UTR constructs drive transcrip-
tion but translation of the minor transcript is inhibited. (a) cDNA
fragments for ﬁreﬂy luciferase (upper band) and GAPDH (lower band)
were speciﬁcally ampliﬁed by RT-PCR using reverse transcribed (+) or
control (no reverse transcription step) () DNAse I-treated total RNA
from transfected HepG2 cells. Images shown are negative contrasts for
purposes of clarity and represent a typical experiment. As shown,
expression of ﬁreﬂy luciferase mRNA was elevated from both the
pGLALASmaj and pGLALASmin 5 0-UTR constructs compared to
the parental pGL3P vector. Experiments were performed on three
separate occasions in duplicate with similar results in each case. (b) To
test for intrinsic transcriptional activity, cDNA fragments encoding the
ALAS1 major or minor 5 0-UTRs were ligated into HindIII/NcoI
digested pGL-3 basic vector (Promega), which lacks eukaryotic
promoter and enhancer sequences, to produce the pBALASmaj and
pBALASmin constructs. In contrast to the parental pGL-3 basic
vector (pGL3B) (not shown), both the pBALASmaj (clear bar) and
pBALASmin (solid bar) constructs were able to drive transcription
producing ﬁreﬂy luciferase mRNA. Values shown on the Y-axis are
arbitrary units from densitometric analysis. Results shown represent
mean (±S.D.) of at least three experiments performed in triplicate.
(c) The relative ﬁreﬂy luciferase activity of the pBALASmin (solid bar)
construct is reduced by nearly 90% compared to the pBALASmaj
(clear bar) construct. Results shown represent mean (±S.D.) of at least
three experiments performed in triplicate.
1064 A.G. Roberts et al. / FEBS Letters 579 (2005) 1061–1066Fenton chemistry, whilst haem deﬁciency may impede the
activity of certain hemoproteins with potentially harmful con-
sequences, particularly with regard to neurodegeneration andageing [18,19]. In liver and probably all other non-erythroid
cells, haem supply is regulated primarily via feedback regula-
tion of ALAS1 mRNA stability, yet the precise mechanism
has not been elucidated. The data produced here in this study
conﬁrmed that the major human ALAS1 mRNA is indeed
destabilised by haem in HepG2 cells with half-life measure-
ments of 2.9 and 6.2 h, in the presence and absence of exoge-
nous haem, respectively, similar to those reported previously
[10]. In contrast, we show for the ﬁrst time that an alterna-
tively-spliced exon in the 5 0-UTR of human ALAS1 mRNA
renders it resistant to haem-mediated decay and inhibits trans-
lation, which provides a crucial insight into the underlying
mechanism by which haem destabilises ALAS1 mRNA.
Regulation of mRNA stability is an important mechanism
in controlling gene expression, involving complex and some-
times poorly understood interactions between mRNA binding
proteins and cis-acting sequence elements, most of which are
located in the 3 0- or 5 0-UTRs [20,21]. The resistance of the
minor ALAS1 mRNA to haem-mediated decay had sug-
gested that the inclusion of exon 1B might disrupt an impor-
tant regulatory element within the 5 0-UTR. As we showed,
however, the ALAS1 major 5 0-UTR was unable to confer
haem-mediated destabilisation on its own. Whilst we cannot
rule out that there are elements within the 5 0-UTR that inter-
act with others elsewhere in the mRNA to bring about haem-
mediated decay, this appears unlikely since there is poor
sequence conservation between the 5 0-UTRs of the major hu-
man, rat and chicken ALAS1 mRNAs, all of which are reg-
ulated by haem [5,8–10]. As we demonstrated, the minor 5 0-
UTR inhibited translation of a downstream heterologous
mRNA and so we propose an alternative hypothesis where
the resistance of the minor ALAS1 mRNA to haem-mediated
decay results from its inhibited translation. Corroborative
evidence for this proposal comes from previous studies where
inhibitors of protein synthesis have been shown to stabilise
ALAS1 mRNA and block haem-mediated decay leading to
the suggestion that the haem eﬀect requires a labile protein
[8,11]. Whilst our data do not exclude the involvement of a
labile trans-acting factor, they suggest strongly for the ﬁrst
time that haem-mediated ALAS1 mRNA decay requires
translation of ALAS1 mRNA itself. Such regulated co-trans-
lational mRNA degradation has been observed for b-tubulin
[22] and c-myc [23].
The process of mRNA turnover is intimately linked to trans-
lation and numerous 5 0-UTRs have been shown to regulate
translation through mRNA-speciﬁc characteristics such as
size, GC content, secondary and tertiary structure, and the
location of potentially active upstream open reading frames
(uORFs) [17], e.g., translation of nitric oxide synthase has been
shown to be regulated by an alternatively spliced 5 0-UTR [24].
The ALAS1 minor 5 0-UTR sequence exhibits a number of fea-
tures that might be responsible for its reduced translation. The
inclusion of exon 1B creates a much longer 5 0-UTR at 303nt
than the 125nt major 5 0-UTR. Whilst it is not particularly
GC rich at 57%, RNA folding algorithms predict that exon
1B forms a moderately stable stem-loop structure
(DG = 38.3 kcal), which might inhibit ribosomal scanning
through it. In addition, exon 1B introduces four potentially ac-
tive, upstream open reading frames (uORFs): uORFs 1, 2, and
4 are located exclusively within exon 1B whilst uORF3 initiates
within exon 1B and terminates 2nt upstream of the ALAS1 ini-
tiating codon in exon 2 (Fig. 4).
Fig. 4. Upstream open reading frames (uORFs) located within the 5 0-UTR of the minor ALAS1 mRNA. Exon 1B is shown in upper case. Four
uORFs are indicated, designated U1 to U4. Potential initiating AUG codons and termination codons are given in bold letters. U1, U2 and U4 all
initiate and terminate within exon 1B, whilst U3 starts in exon 1B and terminates 2nt upstream of the start of the major ALAS1 ORF in exon 2. Of
the uORFs, only 153nt U1 is in frame with the downstream major ALAS1 ORF separated by 54nt of mRNA. The U4 AUG is 1nt upstream of and
overlaps the termination codon of U1. The ALAS1 ORF is shown at +1 with all nucleotide positions numbered accordingly.
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nisms might account for the reduced translation. Furthermore,
the functional signiﬁcance of alternative splicing in the human
ALAS1 gene is not known. It is somewhat paradoxical that it
has evolved in humans and yet, as our data indicate, the minor
mRNA would appear to contribute less than 2% of the
steady-state concentration of ALAS1 protein. The recent Pan
troglodytes genome assembly [25 – November 2003 build] dem-
onstrates a high degree of sequence homology in this region
between humans and chimpanzees, including canonical splice
donor and acceptor sites and the four potential uORFs,
although uORFs 3 and 4 would utilise alternative stop codons
because of a 14 bp insertion in the chimpanzee sequence. The
presence of putative functional uORFs raises the intriguing
prospect that regulated translation of the minor mRNA might
be involved in developmental or tissue-speciﬁc expression of
ALAS1.Acknowledgements:We thank Wales College of Medicine, Cardiﬀ Uni-
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(Department of Medical Biochemistry and Immunology, Cardiﬀ Uni-
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